ARCT: Arcturus Therapeutics Holdings Inc. Stock

by  •  • Comments Off on ARCT: Arcturus Therapeutics Holdings Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 253.57
Enterprise Value ($M) 16.54
Book Value ($M) 240.98
Book Value / Share 8.89
Price / Book 1.05
NCAV ($M) 202.89
NCAV / Share 7.48
Price / NCAV 1.25

Profitability (mra)
Return on Invested Capital (ROIC) -0.30
Return on Assets (ROA) -0.19
Return on Equity (ROE) -0.31

Liquidity (mrq)
Quick Ratio 4.67
Current Ratio 4.67

Balance Sheet (mrq) ($M)
Current Assets 305.98
Assets 344.07
Liabilities 103.09
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 152.31
Operating Income -95.67
Net Income -80.94
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -59.75
Cash from Investing -0.65
Cash from Financing 5.42

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-05 13G State Street Corp 4.90 -18.62
11-08 13G Nikko Asset Management Americas, Inc. 8.56 75.31
11-05 13G Sumitomo Mitsui Trust Holdings, Inc. 8.56 75.31
2024-04-05 13G/A BlackRock, Inc. 10.20 14.37

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-06 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-05 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-11 60,598 277,019 21.88
2025-04-10 128,620 545,398 23.58
2025-04-09 92,270 468,764 19.68
2025-04-08 113,506 432,159 26.26

(click for more detail)

Similar Companies
APGE – Apogee Therapeutics, Inc. APLT – Applied Therapeutics, Inc.
AQST – Aquestive Therapeutics, Inc. ARDX – Ardelyx, Inc.
ATAI – Atai Life Sciences N.V.


Financial data and stock pages provided by
Fintel.io